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Abstract
The tg(cyp19a1b-GFP) transgenic zebrafish expresses GFP (green fluorescent protein) under the control of the cyp19a1b
gene, encoding brain aromatase. This gene has two major characteristics: (i) it is only expressed in radial glial progenitors in
the brain of fish and (ii) it is exquisitely sensitive to estrogens. Based on these properties, we demonstrate that natural or
synthetic hormones (alone or in binary mixture), including androgens or progestagens, and industrial chemicals induce a
concentration-dependent GFP expression in radial glial progenitors. As GFP expression can be quantified by in vivo imaging,
this model presents a very powerful tool to screen and characterize compounds potentially acting as estrogen mimics either
directly or after metabolization by the zebrafish embryo. This study also shows that radial glial cells that act as stem cells are
direct targets for a large panel of endocrine disruptors, calling for more attention regarding the impact of environmental
estrogens and/or certain pharmaceuticals on brain development. Altogether these data identify this in vivo bioassay as an
interesting alternative to detect estrogen mimics in hazard and risk assessment perspective.
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Introduction
Over the last 20 years, numerous examples have documented
the adverse reproductive health effects of man-made compounds
that, released in the environment, are capable of disrupting the
endocrine system in wildlife and human populations [1]. To date,
a growing number of structurally and functionally diverse groups
of chemicals have been proven or suspected to have endocrine-
disrupting chemical (EDCs) activity. Concerns about their effects
on human and wildlife reproductive health have stimulated the
development and implementation of screening and testing
procedures for hazard and risk assessment [2].
EDCs are known to interfere with the endocrine system through
multiple signalling pathways. One major mechanism of EDC
effects involves their action as estrogen receptors (ERs) agonists.
Until now, most studies dedicated to the actions of (xeno)-
estrogens have focused on their effects at the level of the gonads
and other peripheral tissues [2,3]. However, there is emerging
evidence to show that EDCs, notably (xeno)-estrogens, act in the
brain, notably on the development and functioning of the
neuroendocrine circuits. However, at the present stage, such
potential effects of EDCs are not taken into account in risk
assessment, mainly because of the lack of readily accessible and
validated models.
In this context, the cyp19a1b gene, which encodes a brain
form of aromatase (aromatase B) in fish, is of particular
relevance for several reasons. First, as documented in different
species, this gene exhibits exquisite sensitivity to estrogens
[4,5,6]. Second, cyp19a1b expression is strictly limited to radial
glial cells (RGC) that act as neuronal progenitors in both
developing and adult fish [7]. Furthermore, several studies point
to this gene as a sensitive target for estrogen mimics [8,9]. We
have developed a transgenic zebrafish tg(cyp19a1b-GFP) line that
expresses GFP under the control of the cyp19a1b promoter [10].
As evidenced by careful validation procedures, this line shows
perfect co-expression of GFP and endogenous aromatase B in
RGC. The reason why cyp19a1b is only expressed in radial glial
cells (RGC) is not fully understood. Nevertheless, previous
studies showed that the estrogenic regulation of cyp19a1b
expression requires a mandatory interaction between estrogen
receptors acting through an estrogen response element (ERE)
and an unknown glial factor that binds a sequence located
upstream from the ERE in the promoter region of the cyp19a1b
gene [5]. This results in an intriguing positive auto-regulatory
loop through which aromatase, the estrogen-synthesizing
enzyme, is up-regulated by E2 (17ß-estradiol). This loop
explains why aromatase B expression and activity are so high
in the brain of sexually mature adult fish with high levels of sex
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steroids [11,12]. In contrast, in embryos, cyp19a1b expression is
very low but can be strongly activated by E2 exposure as early
as 24 hours post-fertilization, i.e. when both estrogen receptors
and cyp19a1b start to be expressed in the brain [13].
This study aims at investigating the potential of a large spectrum
of ligands, such as natural or synthetic steroids or ubiquitous
environmental contaminants, to alter cyp19a1b-driven GFP
expression in RGCs of developing zebrafish. Because the skull is
transparent at these early development stages, GFP expression can
be easily imaged and quantified in vivo without sacrificing the
animals. The main finding of this study is that a number of
chemicals can indeed target cyp19a1b-GFP expression through
ER-activated mechanisms. These chemicals include established
(xeno)-estrogens, but also several aromatizable or non-aromatiz-
able androgens and synthetic progestagens, evidencing the
usefulness and the validity of the in vivo tg(cyp19a1b-GFP) zebrafish
test for screening compounds, alone or in mixtures.
Methods
Ethics
This study was approved by the ethics committees INERIS
(Institut National de l’Environnement Industriel et des Risques)
and CREEA (Comite´ Rennais d’Ethique en matie`re d’Expe´ri-
mentation Animale) unser permit number EEA B-35-040. All steps
have been taken to reduce suffering of animals. Experiments were
performed in accordance with European Union regulations
concerning the protection of experimental animals (Directive
86/609/EEC).
Chemicals
17b-estradiol (E2), 17a-ethinylestradiol (EE2), estrone (E1),
estriol (E3), diethylstilbestrol (DES), hexestrol (HEX), zearalenol
(Zea), a-zearalenol (a-Zee), b-zearalenol (b-Zee) and a-zearala-
nol (a-Zea), genistein (Gen), diadzein (DZ), 4-tert-octylphenol
Figure 1. Upon exposure of embryos to estradiol, the tg(cyp19a1b-GFP) zebrafish expresses GFP only in radial glial cells. (a) Dorsal
view of a zebrafish larva treated with 10 nM E2 showing that GFP signal is visible in the brain, notably in the telencephalon (tel), preoptic area (poa),
and in the nucleus recessus posterioris (nrp) of the caudal hypothalamus; ob: olfactory bulb. (b) High resolution confocal image showing the RGCs in
the telencephalon (tel), preoptic area (poa), nucleus recessus lateralis (nrl) and nucleus recessus posterioris (nrp) of the caudal hypothalamus. (c) High
power view of the area shown in (b). Soma (s) are located along the midline except in the case of newborn cells (nb) undergoing migration (see
Figure 2). RGCs have long cytoplasmic radial processes (rp) terminating by end-feet (ef) at the brain surface. (a) Bar = 200 mm; (b) Bar = 100 mm (c)
Bar = 20 mm.
doi:10.1371/journal.pone.0036069.g001
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(4tOP), 4-tert-pentylphenol (4tPP), 4-tert-bisphenol A (BPA), 1,1,
1-Trichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane (o,p’-DDT),
Methoxychlor (MXC), 1,1,1-Trichloro-2,2-bis(4-hydroxyphenyl)
ethane (HPTE), Chlordecone (Chlo), Endosulfan (Endo), testos-
terone (Testo), 17a-methyltestosterone (17a-MT), 11-ketotestoster-
one (11-KT), 4,5a-dihydrotestosterone (DHT), 17b-trenbolone
(Trenb), metribolone (R1881), 17a-Ethynyl-19-nortestosterone
(norethindrone, NOR), 13b-Ethyl-17a-ethynyl-17b-hydroxygon-4-
en-3-one (Levonorgestrel, D(-)N), rifampicine (RIF), dexamethasone
(DEX), spironolactone (SPI), corticosterone (COR), Benzophenone
(BP), DiBenzo[a]anthracene, (diB[a]A), Benzo-[a]-pyrene (B[a]P),
chrysene), 4-hydroxyandrostenedione (4-OHA) were obtained from
Sigma-Aldrich Chemical Co. (St.Louis, MO). 2,3,7,8 TetraChloro-
p-DibenzoDioxin (TCDD) was obtained from Promochem
(France), ICI 182-780 (ICI) was purchased from Tocris (USA),
1,4,6-androstatrien-3,17-dione was obtained from Steraloı¨ds (USA).
Stock solutions of chemicals were prepared in dimethyl sulfoxide
(DMSO) and stored at –20uC. Fresh dilutions of test chemicals were
prepared before each experiment.
Animals and Exposures to EDCs
Fertilized cyp19a1b-GFP transgenic zebrafish eggs were
exposed to chemicals or to solvent control (DMSO; 0.01% v/
v). Each experimental group consisted of 30 embryos exposed in
100 ml of water. Embryos were kept in an incubator at 28uC,
under semi-static conditions. Exposures were performed from
0 dpf to 5 dpf (day post-fertilization). At the end of the exposure
period, 5-dpf old zebrafish were processed for cyp19a1b, gfp
expression by PCR or for fluorescence measurement by image
analysis.
For binary mixtures of estrogens, GFP induction, expressed as a
percentage of response relative to E2 5 nM, was measured both
for single compounds (E2, E1 and EE2) and for binary mixtures of
estrogens: E1+E2 at fixed ratio of 1:10 and E2+EE2 at fixed ratio
of 1:1. For each mixture, we performed two independent
experiments. The Concentration Addition (CA) [14] and the
Independent Action (IA) [15] models were used to model the
theoretical concentration-response relationship for binary mixtures
using a Microsoft ExcelTM macro [16]. To test the compliance of
experimental data with CA and IA models, residues (differences
between experimental and theoretical data) were first checked for
normality using Shapiro-Wilk test. Then, a Student t-test
(ddl = n22) was used to test the following H0 hypothesis: the
mean of the residues is equal to 0 (a= 0.05). RTM (R 2.13.1,
software, R development Core Team) was used for statistical
analysis.
RNA Extraction and Quantitative Real-time PCR
After exposure, pools of 10 zebrafish were sonicated (10 sec,
three times) in 250 mL Trizol Reagent (Gibco, Carlsbad, CA,
USA), and total RNA was extracted according to the manufac-
turer’s protocol. Reverse transcription was carried out by
incubating 2 mg total RNA with 5 mM random examer
oligonucleotides, 10 mM DTT, 2.5 mM dNTPs and 100 U
MMLV-RT (Promega) in the appropriate buffer for 30 min at
37uC and 15 min at 42uC. Polymerase chain reaction (PCR) was
performed in an iCycler hermocycler coupled to the MyiQ
detector (Bio-Rad. Hercules, CA, USA) using iQ SYBR-Green
Supermix (Bio-Rad) according to the manufacturer’s protocol.
The following primers were used: EF-1 (fw) 59-AGCAGCAGCT-
GAGGAGTGAT- 39, EF-1 (rev) 59-CCGCATTTGTAGATCA-
GATGG-39; Cyp19a1b (fw) 59-TCGGCACGGCGTGCAACTAC
-39, Cyp19a1b (rev) 59- CATACCTATGCATTGCAGACC-39;
EGFP (fw) 59-CGACGGCAACTACAAGAC -39, EGFP (rev) 59-
TAGTTGTACTCCAGCTTGTGC -39. Expression levels of EF-1
mRNA were used to normalize the expression of other genes.
Melting curve and PCR efficiency analyses were performed to
confirm correct amplification. Each experiment was performed at
least twice in triplicate.
In Vivo Imaging: Confocal Microscopy
Transgenic cyp19a1b-GFP zebrafish were fixed in paraformal-
dehyde and embedded in agarose at 8 dpf. The brain was imaged
with an Olympus FLUOVIEWH FV10i confocal laser scanning
microscope in multiple field of view mode. The 110 images
constituting each of the 9 fields of view were merged plan by plan
and the resulting z-stack was reconstructed in a 3D red-green
anaglyph image with the imageJ program (http://rsb.info.nih.
gov/ij/).
In Vivo Imaging: Wide-field Fluorescence Microscopy
Live tg(cyp19a1b-GFP) embryos were observed in dorsal view
and each was photographed using a Zeiss AxioImager.Z1
fluorescence microscope equipped with a AxioCam Mrm camera
(Zeiss GmbH, Go¨ttingen, Germany). All photographs were taken
using the same parameters: only the head was photographed using
a X10 objective, with a 134 ms exposure time and maximal
intensity. Photographs were analyzed using the Axiovision
Imaging software and fluorescence quantification was realized
using the ImageJ software. For each picture, the integrated density
was measured, i.e. the sum of the gray-values of all the pixels
within the region of interest. A gray-value of 290 was defined as
background value.
Data Analysis
Chemicals were tested in at least two independent experiments.
Data are expressed as a mean fold induction above solvent control
6 standard error of the mean (SEM). Concentration–response
curves were modelled using the Regtox 7.5 Microsoft ExcelTM
macro (available at http://www.normalesup.org/˜ vindimian/
fr_index.html), which uses the Hill equation model and allows
Table 1. Calculated Effective concentrations EC50 for E2, EE2,
E1 and Genistein in transgenic cyp19a1b-GFP zebrafish line
based on measurement of either cyp19a1b or GFP gene
expression by PCR and by image analysis.
Compound Method EC50 (nM) ±CI 95
E2 cyp19a1b mRNA 2.8 2,6122,99
GFP mRNA 4.1 1.5528.16
Image analysis 0.5 0.4520.64
EE2 cyp19a1b mRNA 0.04 0.03120.051
GFP mRNA 0.02 0.01220.028
Image analysis 0.01 0.0120.012
E1 cyp19a1b mRNA 2.3 2.1421.81
GFP mRNA 1.3 0.8822.15
Image analysis 2.4 2.0422.5
Genistein cyp19a1b mRNA 3545 305223556
GFP mRNA 2466 1172219261
Image analysis 2166 187222254
Results are expressed as mean 6 confidence interval at 95% (CI 95).
doi:10.1371/journal.pone.0036069.t001
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Figure 2. In vivo imaging of 5-dpf old live transgenic cyp19a1b-GFP zebrafish embryos exposed to chemicals inducing GFP
expression in radial glial progenitors. Dorsal views (anterior to the top) of the telencephalon (tel), preoptic area (poa), and nucleus recessus
posterioris (nrp) of the caudal hypothalamus. For each chemical the concentration used is indicated. CTRL: solvent control, EE2: 17a-ethinylestradiol,
E2: 17b-estradiol, E1: estrone, E3: estriol, DES: diethystilbestrol, HEX: hexestrol, GEN: genistein, a-ZEA: a-zearalenol, a-ZEE: a-zearalanol, b-ZEE: b-
zearalanol, BPA: bisphenol A, 4-t-PP: 4-t-pentylphenol, 4-t-OP, 4-t octylphenol, NPmix: mixture of nonylphenol, o,p’DDT: 1,1,1-Trichloro-2-(2-
chlorophenyl)-2-(4-chlorophenyl)ethane, MXC: methoxychlor, HPTE 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane, Testo: testosterone, DHT:
dihydotestosterone, 17a-MT: 17a-methyltestosterone, 17b-Trenb: 17b-trenbolone, Noreth.: 17a-Ethynyl-19-nortestosterone, D(-)N: 13b-Ethyl-17a-
ethynyl-17b-hydroxygon-4-en-3-one, ICI (ICI 182-780).
doi:10.1371/journal.pone.0036069.g002
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Table 2. Effective concentrations (EC50), maximum fold of induction measured above solvent control and relative estrogenic
potencies (REP) of various compounds belonging to different chemical families.
Substance EC50 (nM) SD
Max. fold
induction SD CV (%) REP n
Synthetic estrogens EE2 0.013 0.004 18 6.6 31.4 36.6 6
HEX 0.012 0.002 24 2.1 18.6 39.1 3
DES 0.01 0.004 22.8 1.7 36.6 45.8 3
Natural estrogens E1 1.3 0.23 18.8 6.4 18.1 0.36 3
E2 0.48 0.27 16.4 8.5 57.4 1 4
E3 83.9 22.9 8.6 0.5 27.3 0.01 4
4tOP 595 131.5 11.0 4.2 45.0 8.01E-04 3
Alkylphenols 4tPP 2541 503 10.0 3.5 19.8 1.88E-04 4
4NPmix 406 94.4 9.3 0.3 20.9 1.17E-03 4
4-n-NP n.e. - 2
BPA 3303 933 11.5 0.5 28.3 1.44E-04 5
bisphenol Zearalenone 16 3.46 20 1.0 18.5 0.030 3
Phyto & myco-estrogens a-Zearalanol .500 6.9 0.1 7.4 - 2
a-Zearalenol .500 5.5 1.0 9.7 - 2
b-Zearalenol .500 4 0.8 9.7 - 2
Genistein 2501 6.1 8.1 0.3 0.2 1.91E-04 3
Daidzein n.e. - 2
Pesticides op’DDT 257 25.4 11.4 0.6 9.9 1.86E-03 3
MXC 85 19.7 9.0 1.5 23.3 5.63E-03 3
HPTE 477 49.2 7.4 1.6 10.3 9.99E-04 4
Chlordecone n.e. - - - - - 2
Endosulfan n.e. - - - - - 2
Androgens Testosterone 1031 313 11.3 2.3 30 4.63E-04 3
17a-MT 35.4 19.0 4.5 0.013 2
11-Ketotesterone n.e. - - - - - 2
DHT 2003 697 20.9 3.7 35 2.38E-04 3
17b-trenbolone 508 13.3 4.9 9.38E-04 2
R1881 108 8.2 0,47 - 2
Progestagens Norethindrone 9.01 0.58 20.1 4.2 6.4 0.053 3
D(2)Norgestrel 77.1 17.63 19.0 3.3 22.8 6.19E-03 2
Progesterone n.e
Other compounds Spironolactone n.e
Dexamethasone n.e.
Rifampicine n.e.
Corticosterone n.e.
TCDD n.e.
BaP n.e.
BaA n.e.
diBaA n.e.
Chryse`ne n.e.
Benzophenone n.e.
EtOH n.e.
MetOH n.e.
KMnO4 n.e.
Results are expressed as mean 6 standard deviation (SD).
N = number of independent experiments, n.e.: no effect, CV(%) = coefficient of variation inter-assay for EC50. For each experiment, 10–15 transgenic zebrafish embryos
were analyzed per condition.
doi:10.1371/journal.pone.0036069.t002
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Figure 3. Dose-response curves of GFP induction in transgenic cyp19a1b-GFP embryos by various ligands (17a-ethinylestradiol is
used as a reference). (a) Natural estrogens and pharmaceutical compounds: EE2: 17a-ethinylestradiol; E2: 17b-estradiol; E1: estrone; E3: estriol; DES:
diethylstilbestrol; HEX: hexestrol; GEN: genistein; a-ZEA: a-zearalenol; a-ZEE: a-zearalanol; b-ZEE: b-zearalanol. The hexestrol curve in red is hardly
visible because it is very similar to that of DES. (b) Industrial chemicals: BPA: bisphenol A; 4-t-PP: 4-t-pentylphenol; 4-t-OP, 4-t octylphenol; NPmix:
mixture of nonylphenol. (c) Insecticides: o,p’DDT: 1,1,1-Trichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane; MXC: methoxychlor; HPTE 2,2-bis(p-
hydroxyphenyl)-1,1,1-trichloroethane. (d) Androgens: Testo: testosterone; DHT: dihydotestosterone; 17a-MT: 17a-methyltestosterone; 17b-Trenb:
17b-trenbolone; Noreth.: 17a-Ethynyl-19-nortestosterone (norethindrone); D(-)N: 13b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one (levonogestrel),
ICI (ICI 182-780); R1881 (metribolone): androgen receptor agonist.
doi:10.1371/journal.pone.0036069.g003
Figure 4. GFP expression in zebrafish embryos exposed to various ER, AR and PR ligands alone or in combination with ICI. Results
are expressed as fold induction above control (means 6 SEM, n= indicates the number of 5-dpf old zebrafish examined).
doi:10.1371/journal.pone.0036069.g004
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calculation of EC50. For a given chemical, EC50 was defined as
the concentration inducing 50% of its maximal effect. Relative
estrogenic potencies (REP) were determined as the ratio of EC50 of
E2 to that of the test chemical. Correlation analyses between the
EC50 of the tg(cyp19a1b-GFP) and in vitro assays were conducted
on log- transformed EC50 data.
Results
In the cyp19a1b-GFP zebrafish line, GFP expression, perfectly
matching cyp19a1b expression [10], can be strongly stimulated by
estradiol. As visible in Figure 1A, GFP is strictly limited to RGC of
the developing brain. Figure 1B shows the distribution and
organization of the RGC with a high level of resolution in the
brain of an 8 days-old zebrafish larva treated with 10 nM E2.
GFP-expressing RGC exhibit soma located along the brain
ventricles and long cytoplasmic radial processes terminating by
end-feet at the brain surface. GFP-expressing RGC can make
asymmetrical divisions, generating daughter cells that undergo
migration along the radial processes (Figure 1c) and rapidly loose
GFP expression to gain a neuronal phenotype [7,17].
To investigate if this model is relevant for assessing the potency
of EDC to disrupt cyp19a1b in RGC, embryos were exposed for
5 days to increasing concentrations of 45 different compounds
belonging to various chemical classes. The calculated EC50 based
on measurements of cyp19a1b mRNAs, GFP mRNAs or in vivo
imaging showed that the 3 methods yielded similar results
(Table 1), indicating that GFP expression reflects the response of
the endogenous gene. Figure 2 shows examples of the GFP signal
generated by different active compounds. In 5 days-old controls,
GFP expression is weakly detectable in the preoptic area, while
embryos exposed to active compounds exhibit a stronger
fluorescence signal with a much wider distribution from the
anterior telencephalon to the caudal hypothalamus.
Selected compounds with well-known estrogenic activity
included pharmaceuticals estrogens, natural estrogens, phyto and
myco-estrogens, and environmental chemicals. Most of them were
able to induce GFP expression in a concentration-dependent
manner, but clear differences in terms of both EC50 and maximal
induction were observed (Table 2, Figures 2 and 3). As expected,
the synthetic estrogens EE2, HEX and DES were the most active
compounds (Figure 3a) characterized by extremely low EC50s
(10 pM) and maximal inductions around 20 times the basal
expression in controls. Based on their REP (relative estrogenic
potency), they are much more potent than E2 by a factor 37–46.
The natural estrogens, E2 and E1 yielded very similar responses
(Figure 3a), while E3 was active at much higher concentrations
with an REP 175-fold lower than E2. The myco-estrogen
zearalenone (Zea) and its metabolites a-Zea, a-Zee and b-Zee
exhibited different response patterns (Figure 3a). Zea induced a full
concentration-dependent response curve similar to those of the E2
and E1, while the three Zea metabolites did not elicited complete
concentration-response curves. Among isoflavones, genistein was
the only active compound, though at relatively high concentra-
tions, and daidzein was inactive.
Among the various industrial chemicals tested, all alkylphenolic
compounds were active, yielding similar concentration-dependent
responses with the exception of the linear alkylphenol 4-n-NP that
was inactive (Figure 3b). NPmix and 4-tert-OP exhibited similar
Figure 5. Effects of 17a-methyltestosterone and R1881 alone or in combination with either flutamide or ICI. Results are expressed as
fold induction above control (means 6 SEM).
doi:10.1371/journal.pone.0036069.g005
Figure 6. GFP expression in zebrafish embryos exposed to EE2
and TCDD (0.05 nM) alone or in combination. Results are
expressed as fold induction above control (means 6 SEM).
doi:10.1371/journal.pone.0036069.g006
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estrogenic potencies while 4-tert-PP was 6-fold less active than
NPmix. In comparison, the NP mixture was 8-fold more active
than BPA. Several organochlorine pesticides were also tested
(Figure 3b). The DDT-related compounds, o,p’-DDT and MXC,
induced strong GFP expression with similar response patterns
(Figure 3c). Endosulfan and chlordecone were inactive. The strong
effect of MXC is of interest since it is known that its estrogenic
potency is due to biotransformation into estrogenic metabolites.
Among them, bis-desmethyl-MXC (HPTE) was capable of
inducing GFP expression in RGCs. Interestingly, the EC50 of
HPTE was higher than the EC50 for MXC, which could reflect
the additive effect of several estrogenic metabolites derived from
MXC and/or a higher excretion rate of HPTE compared to
MXC. Again, this demonstrates the xenobiotic biotransformation
capacities of embryos.
This is further illustrated by the fact that several natural and
synthetic androgens also induced GFP expression. This was the
case of the aromatizable androgens, T and 17a-MT (Figure 3d) an
effect due to aromatization since it is blocked by co-exposure with
the ER antagonist ICI 182,780 (Figure 4). In agreement,
confirming previous studies [18], the non-aromatizable androgen
11-KT was totally inactive, while DHT, a non-aromatizable
androgen, strongly up-regulates GFP expression (Figure 3d), an
effect blocked by ICI 182-780 (Figure 4). Based on their REP, the
non-aromatizable synthetic androgens, 17b-trenbolone and
R1881, were 4200 and 1000-fold less active than E2, but induced
strong GFP expression by a factor of 20 and 13, respectively
(Figure 3d). These effects could not be blocked by the androgen
receptor antagonist flutamide (Figure 5), but were in contrast
blocked by co-exposure with ICI (Figure 4) In addition, two
synthetic progestins, norethindrone and levonorgestrel, commonly
used in oral contraception and post-menopausal disorders,
induced GFP expression in a concentration-dependent manner
(Figure 3d), while progesterone was inactive. Based on their
respective EC50, norethindrone was 8.5-fold more active com-
pared to levonorgestrel and both exhibited lower estrogenic
potencies compared to E2 (Table 1). Inhibition of progestins-
induced fluorescence in embryos co-exposed with ICI revealed the
involvement of ERs in mediating this effect (Figure 4). To further
evaluate the specificity of the assay in detecting estrogenic activity,
several other compounds were selected. The GR agonist
dexamethasone, the MR antagonist spironolactone, the PXR
agonist rifampicine, several aromatase inhibitors such as anastro-
sole, androstatrienedione and 4-hydroxyandrostenedione, the UV-
filter benzophenone, ethanol, methanol and potassium perman-
ganate were all unable to induce GFP expression.
Because of the ubiquitous character of dioxin-like compounds as
environmental contaminants, agonists of the aryl hydrocarbon
receptor (AhR) were evaluated (TCDD, BaP, BaA, diBaA,
chrysene). None of the AhR agonist ligands were able to induce
GFP expression in RGCs in agreement with previous data [19].
However, co-exposure of embryos to TCDD and EE2, signifi-
cantly down-regulated the EE2-induced fluorescence confirming
the anti-estrogenic effect of TCDD on ER-mediated mechanisms
(Figure 6).
Combination effects of binary mixtures of estrogens were
assessed using the fixed-ratio method. Experimental designs of
mixtures were optimized so that the mixture concentrations
covered a large range of effect predicted by the CA model. The
combined effects of mixture of E1+E2 (ratio 1:10) and E2+EE2
(ratio 1:1), induced GFP expression in a concentration-dependent
manner which were predicted by CA model [14] but not by IA
model [15] (Figure 7).
Discussion
This study confirms the high sensitivity of the cyp19a1b gene to
estrogens and xeno-estrogens in the RGC context [4,6,18]. The
tg(cyp19a1b-GFP) embryo assay is sensitive, fast, and cost effective
for estrogen mimic screening. Twenty-one out of the 45
compounds tested induced GFP expression in a concentration-
dependent manner through ER binding. For several of them, this
study is the first to report estrogenic activity in vivo. In addition,
this study demonstrates that a wide range of EDC targets RGC in
fish brain, raising concern about the consequences of their actions
on brain development and functioning.
The synthetic estrogens (EE2, DEX, HEX) were 37 to 49 times
more potent than E2 with EC50s similar to those previously
Figure 7. Effects of binary mixtures of estrogens on cyp19a1b-GFP expression. The combined effects of mixture of E1+E2 (ratio 1:10) and
E2+EE2 (ratio 1:1) induced GFP expression in a concentration-dependent manner. Mixture means (green) is the mean of two independent assays,
Mixture assays 1 (pale blue) and 2 (red). CA: dose response curve generated by the CA model (black). IA: dose response curve generated by the IA
model (blue).
doi:10.1371/journal.pone.0036069.g007
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reported in the most sensitive fish and human cell-based in vitro
assays [8,20,21]. In transgenic zebrafish stably expressing ERE-
Luciferase [21], EC50s for EE2 and E2 were 10 and 20 times
higher, respectively, than those reported using the tg(cyp19a1b-
GFP) further illustrating the sensitivity of the cyp19a1b gene to
synthetic estrogen and the sensitivity of this line. Zearalenone and
zearalenone metabolites have been well described as ER agonists
in both fish and human in vitro systems [22]. In this study,
zearalenone exhibited a strong concentration-dependant induction
of GFP while zearalenone metabolites induced partial concentra-
tion-response, indicating that zearalenone metabolites generally
behave as partial agonists of fish ERs [20,23]. In agreement,
zearalenone exhibited a comparably strong in vivo effect on
reproduction, notably vitellogenin induction zebrafish, despite its
low in vitro estrogenic potency [24]. The phyto-estrogen genistein
clearly stimulated GFP expression in RGCs in agreement with
previous data [25]. Interestingly, in tg(5xERE:GFP) fish genistein
induced fluorescence in heart and liver, but not in brain [26].
In this assay, industrial chemicals with known estrogenic
activity, such as alkyphenolic compounds (4NPmix, 4-t-OP, 4-t-
PP), BPA, o,p’DDT, MXC, and its estrogenic metabolite HPTE,
were active, in contrast with the fact that NP had no effect in ERE-
luc zebrafish [21], vtg-GFP [27] and 5xERE:GFP [26]. Differences
were also noticed regarding the effect of BPA. In 5xERE:GFP
larvae, BPA activates ER transcriptional activation only in heart
and liver [26], whereas BPA induces GFP expression in RGCs of
developing tg(cyp19a1b-GFP) further confirming recent data (15) of
BPA on cyp19a1b expression in wild type zebrafish. Importantly,
in mammals BPA adversely affects brain development and brain
sexual differentiation [28,29].
In addition to the extreme sensitivity of the cyp19a1b gene, the
biotransformation capacity of the tg(cyp19a1b-GFP) embryo is a
clear advantage over in vitro assays. This is exemplified by MXC
whose metabolites OH-MXC and HPTE directly interact with
ER and potentially show long lasting additive effects [30].
Testosterone and 17a-MT, and the non-aromatisable DHT, but
not 11-KT, were able to induce cyp19a1b expression in RGCs in
an ER-dependant manner. While aromatase converts androgens
into estrogens that subsequently bind to ERs to activate the
cyp19a1b promoter [4,6,18], DHT effect involves conversion into
5a-androstane-3b,17b-diol, a metabolite of DHT with known
estrogenic activity. Conversion of DHT into diols requires 5a-
reductase and 3b-hydroxysteroid dehydrogenase, both of which
are expressed in the brain of developing fish [31] and rodents
[32].
17b-trenbolone acetate is a potent androgen extensively used in
the United States as a growth promoter in beef. It is a recognized
reproductive toxicant in fish [33]. R1881 is the 17-methylated
derivative of 17b-trenbolone and is also a potent non-aromatizable
androgen agonist of fish and human AR [34]. To our knowledge,
this is the first report on the capacity of 17b-trenbolone and
metribolone to activate an ER-dependent gene in a vertebrate.
The metabolic pattern of 17b-trenbolone acetate revealed the
presence of two major metabolites, 17a-trenbolone and trendione
that have low affinity for androgen receptor as compared to 17b-
trenbolone acetate [35], however their affinity towards ERs is
unknown [36]. Progesterone and 19-Nor-testosterone derivatives,
used in contraception, behaved differently in tg(cyp19a1b-GFP)
embryos. Progesterone had no activity as expected from its lack of
estrogenicity [27,37]. But, we show for the first time that
norethindrone and levonorgestrel, both of which are present in
surface waters [38], were very active. In mammals, none of these
compounds binds ERs, but they elicit estrogenic effects when they
are metabolized into 3b, 5a-tetrahydro norethindrone or norges-
trel derivatives, which are likely responsible for the observed in vivo
estrogenic effects of the parent compounds [39,40].
We also addressed the question of the combination effects of
mixture of estrogenic hormones. We show that mixture of E2 and
EE2 (E2+EE2; 1:1) as well as mixture of E1 and E2 (E1+E2; 1:10)
acted in an additive manner on cyp19a1b-driven GFP expression that
was predicted by the CA model, in agreement with previous data on
vitellogenin synthesis [41] or on zebrafish cyp19a1b-luciferase
activity in vitro [8]. It highlights the interest of the tg(cyp19a1b-
GFP) in combination with CA models to assess combined effect of
estrogenic compounds.
In conclusion, the tg(cyp19a1b-GFP) line clearly emerges as a
simple, fast and reliable in vivo assay for monitoring the capacity of
any chemical or its metabolites to activate ER-signalling in vivo at
very early critical developmental stages. It is based on the use of an
endogenous promoter and thus shows of a true physiological brain-
specific response. Its sensitivity is outstanding and comparable to the
most performing in vitro assays [42]. In complement of the in vitro
assay using the same cyp19a1b promoter [8], this in vivo assay will
permit taking into account the biodisponility and pharmaco-
dynamics of chemicals. This will enhance the efficiency and
accuracy of EDCs testing strategies while meeting the 3R policy
(replacement, reduction, refinement) that is enforced by the OECD
(Organisation for Economic Co-operation and Development) and
the main environmental agencies worldwide [43].
Finally, although the potential consequences of such exposures
are unknown, the present data showing direct effects of EDCs on
gene expression in radial glial progenitors raise several serious issues
in the context of risk assessment. One of them is to evaluate to what
extent the present findings may apply to other vertebrates. Some
studies indicate that estrogens indeed affect early brain development
in rodents [44,45,46,47,48], but there is a lack on data the expression
on steroidogenic enzymes, notably aromatase, and estrogen
receptors, notably ERb in the developing brain. Similarly, the roles
of steroids in early aromatase expression [49] are unknown.
Additionally, the potential production and effects of beta-diol,
sometimes referred to as the ‘‘second estrogen’’, have just started to
receive some attention [50], albeit the present work recalls that this
alternative pathway should not be forgotten in the context of
developing animals.
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